Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Review year-by-year annual performance for index funds to uncover patterns that inform proactive asset allocation.
25,727 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Kraken has reportedly secured access to the Fed’s core payment systems, a move that could accelerate settlement times...
A veteran market strategist warns that investors are chasing tech as a safe haven. He expects a broad rotation into h...
A six-month surge in Asia’s 50 largest stocks turned a $10,000 stake into $15,267 by early June 2026, outperforming t...
Investors bias portfolios by political leanings, potentially hurting gains. Experts say open dialogue across camps ca...
A once-overlooked dividend ETF is delivering double-digit gains this year, signaling a shift from megacap leadership ...
A Paychex insider recently moved tens of thousands of shares, prompting questions about the stock’s trajectory. This ...
When a major investor exits a growing SaaS company, the move can shake confidence and the stock. This article examine...
A stock that surged 49% in 2025 can still be tempting in 2026. This guide breaks down how to assess a semiconductor p...
Late-career savers confront a hard truth: retirement funding offers fewer options than college savings. Experts say c...
SpaceX isn’t just about rockets. This investing guide shows how spacex could become most AI company by turning data, ...
In this guide, we compare how Nvidia and Advanced Micro Devices create revenue, what drives their growth, and why inv...